SGLT2 inhibitors; GLP-1 receptor agonists; bariatric surgery; all-cause mortality; cardiovascular diseases; end-stage renal diseases; severe hypoglycaemia; obesity; type 2 diabetes mellitus
Emergency Department, COVID-19, Deliberate self-harm, Suicide, Mental health
COVID-19, SARS-CoV-2, older adults, vaccine booster, neutralizing antibody, T cell response, hybrid immunity
Community vaccination center, Covid-19, Pain, SARS-CoV-2, Self-reported adverse reactions, Severe allergic reactions, Systemic reactions